Last reviewed: June 6, 2026
Last updated: June 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide injections require accurate placement in subcutaneous tissue—the layer between skin and muscle—to work effectively. Learning the correct injection technique, site rotation, and aftercare helps maximize therapeutic benefits and minimize injection-related discomfort. PlexusDx members receive detailed injection instruction with their compounded semaglutide orders.
Understanding Subcutaneous Injection Sites for Semaglutide
Semaglutide enters the subcutaneous tissue layer, which lies approximately one-quarter inch below the skin's surface. The abdomen, thigh, and upper arm are approved injection sites because they contain adequate subcutaneous fat and nerves are less dense than in other body areas. Each site has distinct advantages: the abdomen offers easy access and consistent absorption, the thigh allows self-injection without mirrors, and the upper arm works well when a partner assists.
Site rotation is critical to prevent lipodystrophy—a condition where repeated injections in the same spot cause fatty tissue changes that can alter medication absorption rates. Healthcare providers recommend rotating between the three approved locations weekly and choosing different spots within each area during each injection. This practice maintains consistent drug delivery and reduces local tissue irritation over time.
The abdomen should be injected at least two inches away from the navel to avoid near-abdominal organs and major blood vessels. Thigh injections work best on the outer, front-facing surface where subcutaneous fat is naturally thicker. Upper arm injections typically require assistance since reaching the back of the arm independently is difficult and accuracy may suffer.
Step-by-Step Semaglutide Injection Technique
Begin by washing your hands thoroughly with soap and warm water, then clean the injection site with an alcohol-based swab using circular motions from the center outward. Allow the alcohol to air-dry completely—injecting through wet alcohol causes skin irritation and can reduce absorption. Gather all supplies before starting: the semaglutide pen or syringe, needle, alcohol swab, cotton ball, and a sharps container for safe needle disposal.
Pinch the cleaned skin gently between your thumb and forefinger to create a tent-like fold that elevates the subcutaneous layer. Insert the needle at a 45 to 90-degree angle—a perpendicular approach (90 degrees) works best for most body areas and ensures the needle reaches the subcutaneous tissue rather than penetrating muscle or remaining superficially. Once inserted, release the skin fold and slowly depress the plunger to deliver the medication over 5 to 10 seconds.
After injection, withdraw the needle at the same angle you inserted it and immediately apply gentle pressure with a clean cotton ball for 5 to 10 seconds. Do not massage the injection site, as this can accelerate absorption unpredictably and increase bruising. Place the used needle in an approved sharps container—never recap needles by hand, as this creates serious injury risk.
Managing Injection Site Reactions and Discomfort
Mild redness, bruising, and slight swelling at the injection site occur in 10 to 15 percent of patients and typically resolve within 24 to 48 hours without treatment. Applying ice for 5 to 10 minutes before injection can numb the area and constrict blood vessels, reducing bruising likelihood. Avoiding injections into areas that are already bruised, hardened, or thickened prevents compounding tissue damage and ensures even medication distribution.
Pain during injection usually results from injecting too quickly, using a dull needle, or striking a nerve. Using fresh needles for each injection maintains sharpness, while slowing the medication delivery rate allows tissue to accommodate the volume gradually. If you experience severe pain during injection, stop immediately, withdraw the needle, and contact your healthcare provider—this may indicate improper needle placement or tissue trauma.
Some patients develop small lumps or induration at injection sites after repeated use, which signals lipodystrophy development. Rotating sites meticulously and avoiding the same location for at least four weeks prevents this complication. If induration develops, inform PlexusDx support immediately, as this may require dosing adjustments or site modifications.
Personalized Injection Planning with PlexusDx Genetic Testing
PlexusDx's Precision Peptide Genetic Test identifies variations in key peptide-pathway genes that influence how your body responds to GLP-1 medications like semaglutide. The test analyzes 14 metabolic pathways and 150+ genetic insights, including variants in GLP1R (rs6923761) and GIPR (rs1800437) that correlate with medication response patterns. Genetic predispositions may predict whether standard injection schedules, dose escalation rates, or alternative compounds suit your metabolism better.
Understanding your genetic profile helps PlexusDx clinicians customize your injection protocol to maximize weight loss and minimize side effects unique to your biochemistry. Some genetic variants predict faster or slower medication metabolism, which informs whether you'll benefit from standard dosing intervals or personalized adjustments. The Precision Peptide Genetic Test costs $99 as an add-on after your first month of treatment and provides actionable insights for long-term therapy optimization.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I inject semaglutide into areas other than the abdomen, thigh, and upper arm?
No—only the abdomen, thigh, and upper arm have FDA-approved data for safe subcutaneous semaglutide injection. These sites were selected because they contain adequate subcutaneous fat and show predictable absorption rates. Injecting into unapproved areas may alter medication absorption and increase adverse reactions.
How often should I rotate injection sites to prevent lipodystrophy?
Rotate to a different site location each week and choose a new specific spot within that area at each injection. For example, inject the left abdomen in week one, right abdomen in week two, then move to the thigh. Avoid reusing the same exact location for at least four weeks to prevent fatty tissue changes and maintain consistent drug absorption.
What angle should the needle enter the skin for semaglutide injection?
A 90-degree angle (perpendicular to the skin) is ideal for most patients and ensures the needle reaches the subcutaneous tissue reliably. Some patients with minimal subcutaneous fat may use a 45-degree angle if necessary. PlexusDx provides personalized injection instruction based on your body composition and site characteristics.
Does PlexusDx provide training on how to inject compounded semaglutide safely?
Yes—PlexusDx includes detailed injection technique guidance with every compounded semaglutide order from licensed 503A pharmacies. Members receive written instructions, video demonstrations, and access to support specialists who can answer technique questions. Compounded semaglutide injection starts at $149/month with no flat per-compound pricing changes as your dose adjusts.
Can genetic testing predict how I'll respond to semaglutide injection therapy?
The PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R and other peptide-pathway genes that influence semaglutide metabolism and weight loss response. Testing ($99 after your first treatment month) reveals whether your genetics predict standard response or require personalized dosing adjustments. Results guide clinicians in optimizing your injection schedule for maximum safety and efficacy.
What should I do if I develop bruising or lumps at my injection sites?
Minor bruising resolves naturally within 24 to 48 hours and doesn't require treatment. Persistent lumps or hardening suggest lipodystrophy, which requires aggressive site rotation and possible clinical review. Contact PlexusDx support immediately if induration develops, as this may indicate the need for dosing adjustments or alternative injection strategies.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
NAD+ and Semaglutide Together — Synergistic Benefits
Is There an Oral Semaglutide for Weight Loss? Exploring the Options